Zeitschriftenaufsatz
|
2014
CD52 is a molecular target in advanced systemic mastocytosis.
Autor:in
Hoermann, Gregor; Blatt, Katharina; Greiner, Georg; Putz, Eva Maria; Berger, Angelika; Herrmann, Harald; Cerny-Reiterer, Sabine; Gleixner, Karoline V; Walz, Christoph; Hoetzenecker, Konrad; Müllauer, Leonhard; Reiter, Andreas; Sotlar, Karl; Sexl, Veronika; Valent, Peter; Mayerhofer, Matthias;
Publikationen als Autor:in / Herausgeber:in der Vetmeduni
Journal
Schlagwörter
Adult; Aged; Animals; Antibodies, Monoclonal, Humanized/pharmacology; Antibodies, Monoclonal, Humanized/therapeutic use*; Antigens, CD/analysis*; Antigens, CD/immunology; Antigens, Neoplasm/analysis*; Antigens, Neoplasm/immunology; Antineoplastic Agents/pharmacology; Antineoplastic Agents/therapeutic use*; Cell Line, Tumor; Cells, Cultured; Female; Fetal Blood/cytology; GTP Phosphohydrolases/genetics; GTP Phosphohydrolases/physiology; Genes, ras; Glycoproteins/analysis*; Glycoproteins/immunology; Humans; MAP Kinase Signaling System; Male; Mast Cells/metabolism; Mastocytosis, Systemic/drug therapy; Mastocytosis, Systemic/metabolism*; Membrane Proteins/genetics; Membrane Proteins/physiology; Mice; Mice, Inbred NOD; Mice, SCID; Middle Aged; Molecular Targeted Therapy*; Mutation, Missense; Proto-Oncogene Proteins/genetics; Proto-Oncogene Proteins/physiology; Proto-Oncogene Proteins c-kit/genetics; Transduction, Genetic; Xenograft Model Antitumor Assays; ras Proteins/genetics; ras Proteins/physiology;
Dokumententyp
Originalarbeit
ISSN/eISSN
0892-6638 -
10.1096/fj.14-250894
WoS ID
PubMed ID